Di Wang

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Corrigendum to "CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers" [Cancer Lett. 628 (2025) 217822].

Corrigendum to "CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers" [Cancer Lett. 628 (2025) 217822].

Journal: Cancer letters

Published: July 22, 2026

GAB3 suppresses lung adenocarcinoma progression by inhibiting the MAPK signaling and potentiating CD8+ T cell immunity.

GAB3 suppresses lung adenocarcinoma progression by inhibiting the MAPK signaling and potentiating CD8+ T cell immunity.

Journal: Cancer letters

Published: December 12, 2025

RAD21 drives tumor progression and confers anti-PD-1 resistance by reprogramming tumor-associated macrophages via upregulation of CSF1 signaling.

RAD21 drives tumor progression and confers anti-PD-1 resistance by reprogramming tumor-associated macrophages via upregulation of CSF1 signaling.

Journal: Cancer letters

Published: December 12, 2025

RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy.

RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy.

Journal: Cancer letters

Published: July 29, 2025

Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers.

Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers.

Journal: Signal transduction and targeted therapy

Published: February 07, 2025

CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers.

CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers.

Journal: Cancer letters

Published: January 11, 2025

Abnormally High Expression of DNAJB6 Accelerates Malignant Progression of Lung Adenocarcinoma.

Abnormally High Expression of DNAJB6 Accelerates Malignant Progression of Lung Adenocarcinoma.

Journal: Biomedicines

Published: July 09, 2024

Targeting LSD1 in cancer: Molecular elucidation and recent advances.

Targeting LSD1 in cancer: Molecular elucidation and recent advances.

Journal: Cancer letters

Published: May 09, 2024

CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer.

CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer.

Journal: Cell discovery

Published: July 11, 2023

Single-Cell Transcriptome Identifies Drug-Resistance Signature and Immunosuppressive Microenvironment in Metastatic Small Cell Lung Cancer (Advanced Genetics 2/03).

Single-Cell Transcriptome Identifies Drug-Resistance Signature and Immunosuppressive Microenvironment in Metastatic Small Cell Lung Cancer (Advanced Genetics 2/03).

Journal: Advanced genetics (Hoboken, N.J.)

Published: January 09, 2023

Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions.

Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions.

Journal: Frontiers of medicine

Published: August 22, 2022

Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.

Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.

Journal: Signal transduction and targeted therapy

Published: March 04, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026